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Herpes simplex virus (HSV) has been shown to induce DNA amplification in the host cell genome, which can be suppressed 
by the adeno-associated virus type 2 (AAV-2) rep gene (Heilbronn et aL, 1990, J. ViroL 64, 3012-3018). In an attempt to 
define domains of Rep which are required for this effect a set of expression constructs was generated for Rep mutants 
with either N-terminal and/or C-terminal truncations, with small internal deletions, or with point mutations. In transient 
cotransfection assays these mutants were tested for the inhibition of HSV-induced DNA amplification and in parallel for 
DNA replication of a rep-defective AAV genome. Our data show that the C-terminal region of Rep where spliced and 
unspliced proteins differ is dispensable for both AAV DNA replication and inhibition of HSV-induced DNA amplification. The 
N-terminus of Rep is required for AAV DNA replication, whereas the first 174 amino acids can be deleted without loss of 
function for the inhibition of DNA amplification. Rep52 which starts at methionine 225 is neither sufficient, nor required for 
this effect. We further analyzed the region between amino acids 174 and 225: A stretch of 16 highly hydrophilic amino 
acids is dispensable for the inhibition of DNA amplification, but it is required for AAV DNA replication. Deletion of two short 
motifs spanning putative protein kinase C phosphorylation sites each strongly reduce both AAV DNA replication and inhibition 
of DNA amplification, whereas a single amino acid substitution of one of these sites abolished AAV DNA replication with 
no effect on the inhibition of DNA amplification. Our data show that most, but not all, of the sequence elements within the 
N-terminus of Rep78 required for AAV DNA replication coincide with those required for the inhibition of HSV-induced DNA 
amplification. A replication-negative rsion of Rep78 comprising the internal 60% of the protein still carry the entire inhibitory 
function for HSV-induced DNA amplification. © 1995 Academic Press, Inc. 
INTRODUCTION 
Adeno-associated virus type 2 (AAV-2) belongs to the 
family of parvoviruses, small DNA viruses with a single- 
stranded linear genome of 4.7 kb in length. Whereas the 
autonomous parvoviruses can replicate independently in 
proliferating cells, efficient replication of AAV requires 
coinfection with a helper virus, adenovirus, or herpesvi- 
rus (reviewed in Berns, 1990). The AAV-2 genome is 
flanked by 145-base-pair terminal repeats which serve as 
origins of replication and contain signals for packaging, 
integration, and rescue of the AAV-2 genome (reviewed 
in Muzyczka, 1992). The right half of the genome encodes 
the three capsid proteins VP1, VP2, and VP3, and the left 
half codes for four overlapping, nonstructural proteins 
Rep78, Rep68, Rep52, and Rep40. The mRNAs coding 
for Rep78 and the C-terminally spliced Rep68 initiate at 
the p5 promoter. Rep52 and Rep40 represent N-termi- 
nally truncated versions of Rep78 and Rep68, respec- 
tively, which are expressed from the internal p19 pro- 
moter, rep78/68 is required for AAV DNA replication (Her- 
monat et al., 1984; Tratschin et aL, 1984) and rep52/40 
1 To whom reprint requests should be addressed. 
for the accumulation of single-stranded AAV genomes 
(Chejanovsky and Carter, 1989). Band shift and footprint 
analyses have revealed that Rep78 and Rep68 bind to 
the terminal repeats of AAV (Ashktorab and Srivastava, 
1989; Im and Muzyczka, 1989; Owens eta/., 1991). Both 
proteins have an ATP-dependent DNA helicase activity 
and cut the AAV origin at the terminal resolution site (Im 
and Muzyczka, 1990, 1992), thereby generating a primer 
for AAV DNA replication (Im and Muzyczka, 1989; Snyder 
et aL, 1990; Im and Muzyczka, 1992). In addition, rep is 
also required for AAV gene expression (Labow et al., 
1986; Tratschin et al., 1986; Beaton et al., 1989; McCarty 
etaL, 1991). 
Besides these functions, the Rep proteins exert a 
number of inhibitory activities with no apparent relation 
to the AAV life cycle such as inhibition of transcription 
from heterologous promoters (Labow et aL, 1987; Men- 
delson et al., 1988; Antoni et aL, 1991; Rittner et aL, 
1992), inhibition of cell transformation by cellular or 
viral oncogenes (Hermonat, 1989, 1991; Khleif eta/,, 
1991; Yang et aL, 1992), and inhibition of induceable 
DNA amplification (Heilbronn eta/., 1990). These activi- 
ties are of particular interest for the mechanistic under- 
standing of AAVs oncosuppressive activity. To analyze 
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whether these inhibitory activities are based on a com- 
mon molecular mechanism, or whether different mo- 
iecular activities of the Rep proteins contribute to the 
observed effects, several groups have analyzed do- 
mains of Rep required for AAV DNA replication, for 
gene regulation, or for the inhibition of oncogene-medi- 
ated cell transformation (McCarty et al., 1991; Yang et 
aL, 1992; Owens etaL, 1993; Yang and Trempe, 1993). 
In this report we have analyzed amino acid sequences 
of Rep required for the inhibition of induceable DNA 
amplification and have compared them to those re- 
quired for AAV DNA replication. 
MATERIALS AND METHODS 
Cells and viruses 
HeLa cells and the Chinese hamster cell line Elona 
11 were maintained as described before (Heilbronn and 
zur Hausen, 1989; Weindler and Heilbronn, 1991). Propa- 
gation of HSV-1 strain 17 (Heilbronn and zur Hausen, 
1989) and adenovirus type 2 (Ad2) (Yalkinoglu eta/., 1988) 
have been described before. 
Plasmids 
The plasmid containing cloned, rep-negative AAV-2 
DNA (pTAV2-3) and the pCM-UL series of HSV amplifi- 
cation genes expressed under the control of the 
HCMV-IE promoter have been described before (Heil- 
br0nn and zur Hausen, 1989, Heilbronn et al., 1990). 
pL15tk is a pUC19-based expression vector which car- 
ries the human cytomegalovirus (HCMV)-immediate- 
early(IE) promoter (-598 to +52) and a HSV thymidine 
kinase polyadenylation signal. The open reading frame 
(0RF) for AAV-2 rep was cloned into pL15tk as follows, 
For pCM repl an Aval fragment, nucleotide position 
263 to 2233 (Srivastava et al., 1983)which can express 
Rep78 and possibly a C-terminally truncated version 
of Rep68 was subcloned, pCMrepl was further trun- 
cated by deleting restriction fragments from the 3' end 
of rep as follows, In pOMrep78 the rep open reading 
frame ends at the Dral site at position 2193, in 
pOMrepC1906 at the Kpnl site at position 1906, in 
pOMrepC1886 at the Hindlll site at position 1886, in 
pOMrepC1432 at the Hincll site at position 1432, in 
pCMrepC1049 at the BamHI site at position 1049 (for 
details see Table 1). For pCMrep52 a Bcll/Aval frag- 
ment (nucleotide position 968 to 2238) was subcloned 
into pL15tk. N-terminal deletions, internal deletions, 
and point mutations of Rep were generated as follows, 
TheAval fragment of pTAV-2 (nucleotide positions 263 
t02233) was subcloned into the Smal site of M13 mp18 
and used as a template for site-directed mutagenesis 
(Taylor et al., 1985). The Neol restriction site at position 
626 was destroyed by changing C626 to A, and a new 
Ncol site was introduced at the starting methionine of 
Rep78 by changing 0324 to G (Table 1). This mutation 
also implicated a change of proline (P) 2 to alanine 
(A). The rep open reading frame of the mutant plasmid 
pMM1 was excised from M13 mp18 by digestion with 
Ncol and Xbal and subcloned into pL15tk. The re- 
sulting expression plasmid was designated pM1 (see 
Table 1). pMM1 was used as a master plasmid for 
further mutagenesis as follows= pMM172, pz&TERK, 
pAQTQ, pz~SARY, pK340H, and pM225G were gener- 
ated by introduction of the nucleotide changes outlined 
in Table 1. Mutants pT183A, pS221G, and pT183A/ 
$221G were generated by changing the nucleotides 
as outlined in Table 1 in the plasmid pKEXrepM1 (Rit- 
tner et aL, 1992) by site-directed mutagenesis and sub- 
sequent subcloning into pL15tk. Mutants were identi- 
fied by DNA sequencing. At nucleotide position 370 
we detected a G to A change in comparison to the 
published sequence (Srivastava et al., 1983)which im- 
plicates an amino acid change of G 17to E. This devia- 
tion from the published sequence was confirmed by 
sequence analysis of the original wild-type AAV-2 plas- 
mid pAV-2 (Laughlin et al., 1983). 
Transfection procedure 
Calcium phosphate coprecipitation followed by a 
DMSO shocl< was performed as described before (Heil- 
bronn and zur Hausen, 1989). Each transfection experi- 
ment was repeated at least twice with two different plas- 
mid preparations leading to similar results, 
AAV replication assay 
HeLa cells (3 x 106) were plated on 15-cm-diameter 
dishes. The next day cells were transfected with the AAV- 
2 rep-negative plasmid (pTAV2-3) and cotransfected with 
HCMV-IE promoter-driven expression constructs for rep 
wild-type or mutant proteins. After the DMSO shock cells 
were infected with Ad2 (m.o.i. = 10). Three days later 
cells were harvested. One-third of the cells were pro- 
cessed for Western blotting and two-thirds were used 
for the extraction of genomic DNA as described before 
(Heilbronn and zur Hausen, 1989). The protocol was the 
same when HSV-1 was used as helper virus with the 
following alterations= 8 X 106 HeLa cells were plated, 
and HSV-1 infected cells were harvested after 40 to 48 
hr. AAV DNA replication was analyzed on Southern blots 
with Xbal and Dpnl-digested total genomic DNA as de- 
scribed before (Heilbronn et aL, 1990). 
Analysis of SV40 DNA amplification in Elona cells 
Inhibition of HSV-induced DNA amplification by differ- 
ent rep expression constructs was analyzed in Flona 11 
cells cotransfected with the set of six HSV amplification 
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AAV genes rep 78 
rep 68 
rep 52 
rep 40 
Plasmids 
! 
I 
I 
I I 
I 
AAV inhibition nuclear 
DNA of DNA localization 
replication amplification (IF) 
pM1 + + + 
pM172 - -  + + 
pM172-1 - -  + + 
pCMrep 52 - -  - -  + 
pC1049 - -  - -  - -  
p01432 - -  - -  - -  
pC1886 +/- - -  +/- 
pC1906 + + + 
pCMrep78 + + + 
pCMrep 1 + + + 
pATERK +/- +/- + 
p~.QTQ - -  + + 
pASARY - -  +/- + 
pT183A + + + 
pS221G --  + + 
pT183A/S221G --  + + 
pK340H - -  - -  + 
pM225G + + + 
FIG. I, Summary of the effects of rep mutants on AAV DNA replication and on the inhibition of HSV-induced DNA amplification. (Left) A diagram 
of the AAV-2 rep genes and the mutant rep expression plasmids used in this study is shown. Internal deletions are indicated by dots, an  point 
mutations are indicated by vertical lines. (Right) A summary of the observed effects as documented in Figs. 2 through 6 is shown. +, Wild-type 
phenotype in comparison to Rep78; - ,  negative phenotype; ÷/ - ,  intermediate phenotype. 
genes, exactly as descr ibed before (Heilbronn and zur 
Hausen, 1989; Hei lbronn etaL, 1990). 
Prote in  ana lys i s  
Production of wi ld-type and mutant Rep proteins was  
measured in transfected whole  cell lysates. Cells were 
harvested, washed with phosphate-buffered sal ine (PBS), 
resuspended in buffer A (50 mMTr is /HCI ,  pH 7.5, 60 mM 
NaCI, 0.5 mM DTT, 1 mM EDTA, t mM pepstatin, 10 mM 
sodium bisulfite, and 1 mM phenylmethylsulfonyl f uo- 
ride) and mixed with an equal vo lume of 2X SDS sample 
buffer (Laemmti, 1970), incubated at 95 ° for 5 min and 
sonicated twice for 15 sec to sheer cel lular DNA. Poly- 
pept ides were separated by SDS-po lyacry lamide  gel 
e lectrophoresis  (SDS-PAGE) on 10% polyacrylamide 
gels (Laemmti, 1970) and electrophoret ical ly  transferred 
to nitrocel lulose filters. The equivalent of 2 x 105 cells 
was  loaded per gel slot. Immunodetect ion was  per- 
formed by standard procedures with a polyclonal Rep 
ant iserum (Rittner etaL, 1992), or a monoclonal  Rep anti- 
body (303-9), and subsequent  detection with an alkal ine 
phosphatase-conjugated secondary antibody. 
Immunof luorescence  assays  
HeLa cells were grown on coversl ips to half conflu- 
ency and transfected with different rep expression plas- 
mids. Twelve hours post-transfection coversl ips were 
washed in PBS, f ixed for 10 min in methanol  fo l lowed by 
5 min in acetone at -20  °, and then air-dried. Slides were 
rehydrated in PBS and incubated with a polyclonal Rep 
ant iserum (1,50) (Rittner et aL, 1992). After three washes 
with PBS ant ibodies were visual ized by a 1,40 diluted 
~_~ I - - - -  HSV- - -1  
23.1 kb 
9.4 kb 
FIG. 2. Effects of expression constructs for Rep78 and an ATP-binding 
site mutant on HSV-induced DNA amplification. Southern blot of Sacl- 
restricted genomic DNA of Elona11 cells transfected with the set of 
six HSV amplification genes under the control of the heterologous 
HMCV-IE promoter (pCM-UL5, -UL8, -DBP, -Pol, -UL42, and -UL52, 2 
#g each) and cotransfected with 6 #g of HCMV-IE promoter-driven 
constructs for rep as indicated. The blot was probed with the 32p. 
labeled BstXI-Kpnl fragment of SV40 DNA. The 15-kb band present in 
every lane corresponds tothe genomic restriction fragment carrying the 
integration locus of SV40, whereas the bands around 40 kb represent 
amplified copies of this locus. 
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FIG. 3. (A) Rep protein expression from mutant and wild-type rep expression plasmids. HeLa cells were transfected with the indicated plasmids 
as described under Materials and Methods. Cells were harvested and Rep protein expression was measured on Western blots with polyclonal 
anti-Rep antiserum. As a control, the empty expression plasmid (pL15tk) was transfected. Protein products of mutant pOMrepO1049 (C1049) were 
too small to be resolved in the SDS-PAGE shown here. For determination of positions of Rep78, Rep68, and Rep52 a HeLa cell extract from cells 
infected with AAV-2 and Ad2 was run in parallel. (B) Subcellular localization of Rep proteins. HeLa cells were transfected with plasmids pL15tk 
(control), pM1, pCMrep52, pM172, pOMrepC1049, pCMrepC1432, pCMrepC1886, and pOMrepC1906 and 12 hr later analyzed by indirect immunofiuo- 
rescence with the polyclonal anti-Rep antiserum. 
fluorescein isothiocyanate-conjugated goat anti-rabbit 
immunogiobulin (Nordic, Talburg, Germany), washed 
again in PBS, dipped in 100% air-dried ethanol, and em- 
bedded in EIvanol. 
RESULTS 
Rep78 is sufficient for the inhibition of SV40 DNA 
amplification 
In a previous report we identified the AAV rep gene 
as being responsible for the inhibition of HSV-induced 
DNA amplification of integrated SV40 DNA sequences 
in a SV40-transformed hamster cell line. Amplification 
of chromosomally integrated SV40 DNA sequences 
has been shown before to be a suitable model system 
for the genetic analysis of inducing and inhibiting 
genes in a transient short-term assay system (Heil- 
bronn etaL, 1990). Since rep encodes several partially 
overlapping proteins (Fig. 1) we asked whether full- 
length Rep78 alone is sufficient for the inhibition of 
HSV-induced DNA amplification. The in-frame initiation 
codon for Rep52, methionine (M) 225 was changed to 
glycin (G) by site-directed mutagenesis and the rep 
0RF expressed under the control of the HCMV-IE pro- 
meter. As is evident from Fig. 2, mutant pM225G which 
cannot express Rep52/40 (data not shown) is able to 
inhibit SV40 DNA amplification to the same extent as 
wild-type rep (pM1) (Fig. 2). Mutation of a consensus 
ATP-binding site (K340H) has been shown before to 
lead to a loss of AAV DNA replication (Chejanovsky 
and Carter, 1990) and of terminal resolution activity of 
Rep (McOarty etaL, 1991; Owens eta/., 1993). A simi- 
larly constructed Rep mutant had also lost the ability 
to inhibit HSV-induced DNA amplification (Fig. 2). 
Expression and localization of N- and C-terminally 
truncated AAV Rep proteins 
To analyze regions within the 621 amino acid Rep78 
protein which are required for the inhibition of HSV-in- 
duced DNA amplification we constructed a number of N- 
and/or C-terminally truncated Rep mutants (Fig. 1) as 
outlined under Materials and Methods. Expression of 
the mutant proteins was verified on Western blots of 
transfected HeLa cell extracts using a polyclonal Rep- 
antiserum. As can be seen in Fig. 3A all mutants are 
expressed at levels comparable to those of wild-type 
Rep78 (lanes, M1, rep78, and repl). The N-terminally de- 
leted mutants correspond exactly to the predicted sizes, 
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TABLE 1 
Plasmid designation Amino acid changes in Rep78 Nucleotide changes in AAV-2 sequence 
pM1 P2A A1-320, 
pM172 Z&1-171 /',1-833; 
pM172-1 A1-171; A530-621 A1-833; 
R529S 
pCMrep52 Z~1-224 /k1-968; 
pCMrepC1049 /',246-621 /',1-262; 
Q244L 
pCMrepC1432 A372-621! /',1-262; 
pCMrepC 1886 A523- 621 ~ /', 1 - 262; 
pCMrepC1906 A530-621 A1-262; 
R529S 
pCMrep78 None A1-262; 
pOMrepl None /k1-262; 
pATERK A183-187 A1-320; 
P2A 
pAQTQ A197-212 A1-320; 
P2A 
p~SARY A221-224 /k1-320; 
P2A 
pK340H K340H Z~1-320; 
P2A 
pM225G M226G A1-320; 
P2A 
pT183A T183A A1-320; 
P2A 
pS221G $221G A1-320; 
P2A 
pT183A/S221 G T183A ~1-320; 
$221G 
P2A 
C324G; 0626A; A2238-4674 
/k2238-4674 
A1906-4674 
A2238-4674 
A1051-4674 
z& 1434- 4674 
A1887-4674 
A1906-4674 
A2194-4674 
A2238-4674 
0324G; 0626A; ~867-881; A2238-4674 
C324G; 0626A; A909-956; A2238-4674 
C324G; 0626A; A981-992; A2238-4674 
0324G; C626A; A13380; G1340T; A2238-4674 
0324G; 0626A; A993G; T994G; A2238-4674 
0324G; 0626A; A867G; A2238-4674 
C324G; 0626A; T981G; C982G; A2238-4674 
0324G; 0626A; A867G; T981G; 0982G A2238-4674 
Note. Deletions are indicated by /',. The numbers behind /~ indicate the positions of deleted AAV-2 nucieotides, or of deleted amino acids of 
Rep78, respectively. The numbering is according to the published AAV-2 DNA sequence (Srivastava et aL, 1983). Single amino acid changes are 
indicated as follows: First the original amino acid (one-letter code), then the amino acid position in the Rep78 protein sequence, and then the new 
amino acid. Single nucleotide exchanges are indicated in the same manner but using the nucleotide sequence of AAV-2 as numbering system. 
a 01432 carries an extension of 9 amino acids at the C-terminus (LQGEMGEAN). 
b 01886 carries an extension of 44 amino acids at its C-terminus (LESTCRGRWGRLTETRKETIPEGTRAMTEIKRQNKTHGCWVVCS). 
whereas some of the C-terminal truncations of Rep are 
extended by a varying stretch of translated vector se- 
quences (Table 1). The shortest C-terminal deletion 
(pCMrepC1049) was not resolved in the gel shown here 
(Fig. 3A) but was clearly detected by immunofluores- 
cence (Fig. 3B). 
The intracellular localization of wild-type and mutant 
Rep proteins was monitored by indirect immunofluores- 
cence using the polyclonal Rep antiserum. Whereas full- 
length Rep and the N-terminally deleted versions are 
properly located in the nucleus, the C-terminal deletion 
mutants pCMrepC1432 and pCMrepC1049 show 
an exclusive cytoplasmic staining (Fig. 3B). Mutant 
pOMrepC1886 could be detected in the nucleus as well 
as in the cytoplasm. This implies that by deleting se- 
quences between nucleotide positions 1432 and 1886, 
the nuclear localization signal is lost. This observation 
is in accordance with the finding of Yang et al. (1992) 
that internal deletions of Rep from nucleotide 1684 to 
1878 or 1765 to 1985 resulted in a loss of nuclear local- 
ization. 
Influence of C- or N-terminally deleted Rep proteins 
on AAV DNA replication and SV40 DNA amplification 
The set of N- and C-terminally truncated Rep proteins 
was first tested for their ability to complement AAV DNA 
replication of the rep-defective AAV-2 plasmid pTAV2-3 
(Heilbronn et aL, 1990). HeLa cells were cotransfected 
with pTAV2-3 and individual rep expression plasmids fol- 
lowed by adenovirus infection. After 3 days, genomic 
DNA was isolated, digested by Dpnl and Xbal, and ana- 
lyzed by Southern blot hybridization with 32P-labeled 
AAV-2 DNA (Fig. 4A). Full-length Rep (pM1, pCMrep78, 
pCMrepl) effectively complements replication of pTAV2- 
3, whereas the N-terminally deleted Rep mutants pM172 
and pCMrep52 are replication-deficient. For Rep52 this 
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Fte. 4. Effects of truncated Rep proteins on AAV DNA replication and 
inhibition of HSV-induced DNA amplification. (A) Southern blot of Xbal 
and Dpnl-digested genomic DNA of HeLa cells cotransfected with the 
AAV-2 rep-negative mutant pTAV2-3 and individual rep expression con- 
structs as indicated. The blot was probed with 32P-labeled AAV-2 DNA. 
RF1 and RF2 represent AAV-2 replication intermediates, double- 
strsnded monomer (4.7 kb, RF1) and double-stranded dimer (9.3 kb, 
RF2). (B) Inhibition of HSV-induced DNA amplification by the indicated 
Rep-expression constructs was assayed as outlined in the legend to 
Fig. 2. 
result was expected from previous reports that Rep52 
and/or 40 proteins are not required for AAV DNA replica- 
tion in vivo (Chejanovsky and Carter, 1989) nor in vitro 
(Ni et al., 1994). The 51 amino acids by which pM172 
extends Rep52 are obviously not sufficient to restore rep- 
lication functions. The series of C-terminally truncated 
Rep proteins complement AAV DNA replication up to the 
point (amino acid 523) where they lose nuclear localiza- 
tion (see Fig. 3B), which is in agreement with observa- 
tions of Yang et al. (1992). All mutants were also tested 
forAAV DNA replication in the presence of HSV-1 as a 
helper with identical results (data not shown). The capac- 
ity of the mutated Rep proteins to inhibit HSV-induced 
DNA amplification is congruent with their ability to com- 
plement AAV-2 DNA replication, with the exception of 
mutant pM172 (Fig. 4B). This mutant effectively inhibits 
DNA amplification, although it is unable to complement 
pTAV2-3 for AAV-2 DNA replication. That means that the 
51 amino acids by which pM172 extends Rep52 contain 
sequence elements which are necessary for Rep-medi- 
ated inhibition of DNA amplification. A minimal Rep ex- 
pression construct (pM172-1; see Fig. 1) spanning the 
internal 60% of the rep ORF (M172 up to Y530) was con- 
structed and found to be able to inhibit HSV-induced 
DNA amplification (Fig. 5C, lane M172-1). 
In order to further dissect the 51-amino-acid sequence 
upstream of the Rep52 start methionine small deletions 
were introduced into pM 1 at two predicted protein kinase 
C phosphorylation sites which are located at the borders 
of this sequence element. They include deletion of T183 
to R187 or of $221 to Y224 (Fig. 1; pATERK, pz~SARY). 
In the center between these two motifs an additional 
potential phosphorylation site for the DNA-activated pro- 
tein kinase (Anderson, 1993 and references therein) was 
found, which is embedded in a highly hydrophilic cluster 
of amino acids. This group of amino acids from $196 to 
D212 was deleted in pAQTQ (Fig. 1). Expression of these 
proteins was controlled by Western blotting (Fig. 5A) and 
immunofiuorescence (data not shown). All mutant pro- 
teins were found to have relative molecular weights of 
the expected sizes and to be located in the nucleus. 
Whereas pz&SARY and pAQTQ were completely defec- 
tive for AAV DNA replication, pz&TERK only showed a 
strong reduction in replication efficiency (Fig. 5B) which 
may be due to the somewhat lower expression level of 
this construct (Fig. 5A). We assume that a higher expres- 
s/on level would restore the ability of this mutant to com- 
plement DNA replication. The results of the amplification 
assay show a different pattern (Fig. 5C). The extensive 
deletion of the domain with the highest hydrophilicity of 
the entire Rep molecule (pz&QTQ) had no influence on 
the ability of Rep to inhibit DNA amplification, whereas 
deletion of either one of the two postulated protein kinase 
C phosphorylation sites clearly reduced the ability of Rep 
to inhibit DNA amplification. For pATERK the results are 
difficult to interpret since the low expression level might 
be the reason for the reduced inhibition of DNA amplifica- 
tion. 
To evaluate whether the amino acids predicted to be 
phosphorylated by PKC were indeed involved in this ef- 
fect, serine 221 was mutated to glycine ($221G) and thre- 
onine 183 was mutated to alanine (T183A) by single 
amino acid substitution within pM1. The mutants were 
correctly expressed as judged by Western blotting (Fig. 
60) and showed nuclear fluorescence (data not shown). 
Whereas pS221G had lost the ability to replicate AAV, 
pT183A behaved like wild-type Rep (Fig. 6A). A double 
mutant (pT183A/S221G) behaved like pS221G as ex- 
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FIG. 5. Effects of internal deletions between M172 and M225 on AAV DNA replication and inhibition of HSV-induced DNA amplification. (A) 
Expression of the mutated Rep proteins as controlled by Western blotting. The position of Rep7"8 is indicated. (B) Complementation of AAV DNA 
replication of pTAV2-3 (rep-negative) by the respective mutant Rep expression constructs. The assay was performed as described in the legend to 
Fig. 4A. (C) Inhibition of HSV-induced DNA amplification by the indicated Rep-expression constructs as outlined in Fig. 2. 
pected. Each of the mutants was able to inhibit DNA 
amplification as did wild-type Rep (Fig. 6B), which is at 
variance with the results obtained from mutants with 
pATERK and pASARY (Fig. 5C). 
DISCUSSION 
In a previous report we showed that the AAV-2 rep 
gene is the only AAV-2 function required for the AAV- 
mediated inhibition of HSV-induced SV40 DNA amplifica- 
tion (Heilbronn et aL, 1990). Here we show that Rep78 is 
sufficient to mediate this effect and that the Rep proteins 
transcribed from the p19 promoter (Rep52 and Rep40) 
are neither sufficient nor required for the observed inhibi- 
tion of DNA amplification. In addition, we provide clear 
evidence that the C-terminal part of Rep78 that is not 
present in the spliced version (Rep68) is not essential for 
the inhibition of HSV-induced DNA amplification. Parallel 
analysis of the ability to replicate AAV DNA showed simi- 
lar sequence requirements. This result is in accordance 
with previous observations that the N-terminus of Rep78 
is required for AAV DNA replication (McCarty etal., 1992; 
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FIG. 6. Effects of point mutations of potential protein kinase C phosphorylation sites within Rep on AAV DNA replication and inhibition of HSV- 
induced DNA amplification, (A) Complementation of AAV DNA replication of pTAV2-3 (rep-negative) by the respective mutant Rep expression 
constructs. The assay was performed as described in the legend to Fig. 4A. (B) Inhibition of HSV-induced DNA amplification by the indicated rep- 
expression constructs as outlined in the legend to Fig. 2. (C) Expression of mutated Rep proteins as analyzed by Western blotting. 
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Yang eta/., 1992), whereas the C-terminus of Rep from 
amino acid 523 downstream is dispensable (Yang et aL, 
1992). Obviously, the acidic amino acids at the very C- 
terminus of Rep are not required for DNA replication. 
Further deletion of C-terminal sequences led to the 
loss of both inhibition of HSV-induced DNA amplification 
and complementation of AAV DNA replication. This coin- 
cided with a loss of nuclear localization of Rep which 
suggests that the loss of function is at least in part a 
consequence of the aberrant subcellular localization of 
Rep. The same explanation appears to apply for the repli- 
cation-negative phenotype of an AAV mutant which was 
deleted at nucleotide position 1861 (Tratschin et aL, 
1984). These deletions overlap a 20 amino acid region 
(G490 to E510) which contains two clusters of basic 
amino acids separated by a spacer of 10 to 12 amino 
acids. Similar motifs are typical for bipartite nuclear local- 
ization signals found in a variety of nuclear proteins 
(Kleinschmidt and Seiter, 1988; Robbins eta/., 1991; Bou- 
likas, 1993). Two in-frame deletions spanning this region 
of Rep were shown to prevent nuclear localization of Rep 
(Yang eta/., 1992) and AAV DNA replication. Clustered 
point mutations of the critical basic amino acids showed 
that these are in fact required for nuclear localization of 
Rep (J. Kleinschmidt, unpublished observation). Muta- 
tions which abolished the nuclear localization of Rep led 
to a loss of any Rep-associated in vivo function measured 
so far. 
A single amino acid exchange within the putative ATP- 
binding site of Rep (K340H) has been shown before to 
lead to a complete loss of replication activity (Chejanov- 
sky and Carter, 1990; McCarty eta/., 1991; Yang eta/., 
1992). We show here that the ability of Rep to inhibit 
HSV-induced DNA amplification is lost as well. The intact 
ATP-binding site is needed for terminal resolution of the 
AAV ends during AAV DNA replication (Chejanovsky and 
0arter, 1990; McCa rty eta/., 1991 ; Ya ng et al., 1992) which 
implicates an ATP-dependent helicase activity of Rep. It 
is unclear whether this is a critical activity needed for 
the inhibition of HSV-induced DNA amplification. Since 
HSV-induced amplification of SV40 DNA is dependent on 
SV40 large T antigen (Danovich and Frenkel, 1988; Matz, 
1989) one could speculate that Rep might interfere with 
the origin-dependent helicase activity of SV40 large T 
antigen. 
All Rep mutants showed comparable activities in both 
AAV DNA replication and inhibition of HSV-induced DNA 
amplification, with the exception of mutants with defects 
between amino acids 171 and 225 (start site of Rep52). 
An N-terminal truncation of the first 171 amino acids of 
Rep78 led to a complete loss of replication activity but 
exhibited full inhibition of HSV-induced DNA amplifica- 
tion. This activity was lost upon further deletion of an- 
other 51 amino acids, suggesting that the region up- 
stream of the Rep52 start site contains information re- 
quired for this function. Further analysis of critical amino 
acids within this region showed that a highly hydrophilic 
stretch of 16 amino acids (pz&QTQ) is dispensable for 
the inhibition of DNA amplification but is required for AAV 
DNA replication. Also, the single amino acid exchange in 
pS221G which mutates a postulated PKC phosphoryla- 
tion site showed the same effect, whereas pT183A be- 
haved like wild-type. It is not known at present whether 
Rep78 is phosphorylated which would be expected in 
analogy to the Rep-analogous NSl proteins of autono- 
mous parvoviruses (Cotmore and Tattersall, 1986). The 
serine at position 221 would be a good candidate for 
phosphorylation. Surprisingly mutants p2~TERK and 
pASARY had a phenotype that was different from pT183A 
or pS221G, respectively. We must therefore assume that 
the additional amino acids deleted in pz&TERK and 
pASARY are either directly involved in the inhibition of 
DNA amplification or indirectly required for the mainte- 
nance of the correct conformation of the Rep molecule. 
Taken together our data confirm previous reports 
(McCarty eta/., 1991; Yang et a/., 1992) that nearly the 
entire coding sequence of Rep78 up to the point where 
spliced and unspliced Rep proteins differ is required for 
its replication function. Very few in-frame deletions or 
single amino acid exchanges are tolerated without loss 
of function. On the other hand, inhibition of HSV-induced 
DNA amplification is fully retained by a N- and C-termi- 
nally truncated version of Rep (amino acid 172 up to 530) 
which roughly comprises 60% of the Rep molecule. In 
addition, most of the internal mutations howed a parallel 
phenotype for DNA amplification and AAV DNA replica- 
tion. The only exceptions are mutants pz&QTQ and 
pS221G which behaved like wild-type Rep in the inhibi- 
tion of DNA amplification but have lost the ability to repli- 
cate AAV. Since we were unable to find any mutant with 
the reverse phenotype we assume that the mechanism 
of Rep interference with HSV-induced DNA amplification 
most likely represents an interference at the level of DNA 
replication possibly by a competitive inhibition. This abil- 
ity to interfere is still retained in a truncated version of 
Rep78 which does not mediate AAV DNA replication any 
more. 
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